Colgate-Palmolive stock has underperformed the broader market over the past year, while analysts remain moderately bullish ...

Colgate-Palmolive’s third quarter results reflected a stable but challenging consumer environment, as the company delivered ...

We recently published 11 Latest Stocks Jim Cramer Talked About. Colgate-Palmolive Company (NYSE:CL) is one of the stocks Jim ...

The consumer products giant reported third-quarter adjusted earnings per share of 91 cents, beating the analyst consensus estimate of 89 cents. Quarterly sales of $5.131 billion were in line with the ...

Detailed price information for Colgate-Palmolive Company (CL-N) from The Globe and Mail including charting and trades.

(Reuters) -Toothpaste maker Colgate-Palmolive cut its annual sales forecast on Friday, in a sign that rising economic ...

Fintel reports that on November 3, 2025, JP Morgan maintained coverage of Colgate-Palmolive (NYSE:CL) with a Overweight ...

CL shares are down after reporting Q3 results, but expect growth thanks to new strategy and strong market share. Keep an eye ...

Colgate-Palmolive Co.’s stock gave back early gains to trade flat on Friday, after the consumer goods giant beat first-quarter earnings estimates and raised its guidance. The company had net income of ...

We came across a bullish thesis on Colgate-Palmolive Company on Investing Lawyer’s Substack. In this article, we will summarize the bulls’ thesis on CL. Colgate-Palmolive Company’s share was trading ...

Colgate-Palmolive and Introgen Therapeutics, Austin, Tex, biotechnology company, announce alliance to incorporate gene therapy into mouthwashes, gels and similar products to treat and prevent oral ...

Shares of Colgate-Palmolive Company (NYSE:CL – Get Free Report) have received an average rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, MarketBeat.com ...